LET’S WORK TOGETHER TO ADVANCE PSORIASIS LEADERSHIP TOWARDS A WORLD FREE OF PSORIASIS
Your donations help the IPC achieve our vision of a world free of psoriasis . We are a global network of over 100 psoriasis experts, thought leaders, and professionals, dedicated to improving patient care around the globe. We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.
You can support the IPC by providing unrestricted funds through our Corporate Membership program or by sponsoring one of our important education, research or patient care initiatives.
For more information on supporting the International Psoriasis Council, please contact Tina Burke, Corporate Relations Director Tina.Burke@psoriasiscouncil.org
Latest news European Commission approves SKYRIZI® for psoriatic arthritis in adultsNovember 22, 2021The European Commission has approved SKYRIZI® for the treatment of active psoriatic arthritis in adults. Focus on Psoriasis – A Report from the 2021 Virtual EADV CongressNovember 18, 2021The European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical practice updates. You can download the full report or read a brief look at some of the highlights. PsoProtect Registry Data UpdateNovember 04, 2021PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,272 cases. Update on spesolimab for generalized pustular psoriasisNovember 02, 2021The European Medicines Agency (EMA) has accepted to review Boehringer Ingelheim’s marketing authorization application (MAA) for spesolimab to treat flares in generalised pustular psoriasis (GPP). More News